{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T13:02:05Z","timestamp":1791378125492,"version":"4.3.2"},"reference-count":24,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,10]]},"DOI":"10.1681\/asn.2012121200","type":"journal-article","created":{"date-parts":[[2013,6,29]],"date-time":"2013-06-29T04:10:59Z","timestamp":1372479059000},"page":"1689-1697","source":"Crossref","is-referenced-by-count":157,"title":["Mycophenolate Mofetil versus Cyclosporin A in Children with Frequently Relapsing Nephrotic Syndrome"],"prefix":"10.1681","volume":"24","author":[{"given":"Jutta","family":"Gellermann","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lutz","family":"Weber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars","family":"Pape","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Burkhard","family":"T\u00f6nshoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Hoyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uwe","family":"Querfeld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R3-21-20230208","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1681\/ASN.V85769","article-title":"Prognostic significance of the early course of minimal change nephrotic syndrome: Report of the International Study of Kidney Disease in Children.","volume":"8","author":"Tarshish","year":"1997","journal-title":"J Am Soc Nephrol"},{"key":"R6-21-20230208","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1007\/s00467-003-1170-9","article-title":"Cyclophosphamide in steroid-sensitive nephrotic syndrome: Outcome and outlook.","volume":"18","author":"Vester","year":"2003","journal-title":"Pediatr Nephrol"},{"key":"R7-21-20230208","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1093\/ndt\/gfq405","article-title":"Long-term effects of cyclophosphamide therapy in steroid-dependent or frequently relapsing idiopathic nephrotic syndrome.","volume":"26","author":"Cammas","year":"2011","journal-title":"Nephrol Dial Transplant"},{"key":"R8-21-20230208","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1038\/ki.2008.24","article-title":"Effective and safe treatment with cyclosporine in nephrotic children: A prospective, randomized multicenter trial.","volume":"73","author":"Ishikura","year":"2008","journal-title":"Kidney Int"},{"key":"R9-21-20230208","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.2215\/CJN.01520209","article-title":"Risk factors for cyclosporin A nephrotoxicity in children with steroid-dependant nephrotic syndrome.","volume":"4","author":"Kengne-Wafo","year":"2009","journal-title":"Clin J Am Soc Nephrol"},{"key":"R10-21-20230208","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1007\/s00467-005-1964-z","article-title":"Mycophenolate mofetil therapy in frequently relapsing steroid-dependent and steroid-resistant nephrotic syndrome of childhood: Current status and future directions.","volume":"20","author":"Moudgil","year":"2005","journal-title":"Pediatr Nephrol"},{"key":"R11-21-20230208","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1053\/j.ajkd.2003.08.011","article-title":"Mycophenolate mofetil and prednisolone therapy in children with steroid-dependent nephrotic syndrome.","volume":"42","author":"Bagga","year":"2003","journal-title":"Am J Kidney Dis"},{"key":"R12-21-20230208","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1007\/s00467-005-1957-y","article-title":"Efficacy of mycophenolate mofetil in pediatric patients with steroid-dependent nephrotic syndrome.","volume":"20","author":"Novak","year":"2005","journal-title":"Pediatr Nephrol"},{"key":"R13-21-20230208","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/s00467-006-0294-0","article-title":"A prospective study on the use of mycophenolate mofetil in children with cyclosporine-dependent nephrotic syndrome.","volume":"22","author":"Fujinaga","year":"2007","journal-title":"Pediatr Nephrol"},{"key":"R14-21-20230208","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1007\/s00467-007-0617-9","article-title":"Treatment with mycophenolate mofetil and prednisolone for steroid-dependent nephrotic syndrome.","volume":"22","author":"Afzal","year":"2007","journal-title":"Pediatr Nephrol"},{"key":"R15-21-20230208","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.1007\/s00467-008-0899-6","article-title":"Mycophenolate mofetil versus cyclosporine for remission maintenance in nephrotic syndrome.","volume":"23","author":"Dorresteijn","year":"2008","journal-title":"Pediatr Nephrol"},{"key":"R16-21-20230208","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1007\/s00467-011-2006-7","article-title":"Mycophenolate mofetil for steroid-dependent nephrotic syndrome: A phase II Bayesian trial.","volume":"27","author":"Baudouin","year":"2012","journal-title":"Pediatr Nephrol"},{"key":"R17-21-20230208","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1007\/s00467-005-1877-x","article-title":"Mycophenolate mofetil in steroid\/cyclosporine-dependent\/resistant nephrotic syndrome.","volume":"20","author":"Mendiz\u00e1bal","year":"2005","journal-title":"Pediatr Nephrol"},{"key":"R18-21-20230208","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.2215\/CJN.00550206","article-title":"Mycophenolate mofetil in children with frequently relapsing nephrotic syndrome: A report from the Southwest Pediatric Nephrology Study Group.","volume":"1","author":"Hogg","year":"2006","journal-title":"Clin J Am Soc Nephrol"},{"key":"R19-21-20230208","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1681\/ASN.V133759","article-title":"The pharmacokinetic-pharmacodynamic relationship for total and free mycophenolic acid in pediatric renal transplant recipients: A report of the german study group on mycophenolate mofetil therapy.","volume":"13","author":"Weber","year":"2002","journal-title":"J Am Soc Nephrol"},{"key":"R20-21-20230208","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.phrs.2011.01.009","article-title":"Development of a Bayesian estimator for the therapeutic drug monitoring of mycophenolate mofetil in children with idiopathic nephrotic syndrome.","volume":"63","author":"Saint-Marcoux","year":"2011","journal-title":"Pharmacol Res"},{"key":"R21-21-20230208","doi-asserted-by":"crossref","first-page":"341","DOI":"10.2215\/CJN.07111009","article-title":"Consensus report on therapeutic drug monitoring of mycophenolic acid in solid organ transplantation.","volume":"5","author":"Kuypers","year":"2010","journal-title":"Clin J Am Soc Nephrol"},{"key":"R22-21-20230208","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1007\/s004670000520","article-title":"A pharmacokinetic study of Neoral in childhood steroid-dependent nephrotic syndrome.","volume":"16","author":"Niaudet","year":"2001","journal-title":"Pediatr Nephrol"},{"key":"R23-21-20230208","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1093\/ndt\/gfh803","article-title":"How should microemulsified cyclosporine A (Neoral) therapy in patients with nephrotic syndrome be monitored?","volume":"20","author":"Filler","year":"2005","journal-title":"Nephrol Dial Transplant"},{"key":"R24-21-20230208","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/s00467-003-1300-4","article-title":"Frequently relapsing nephrotic syndrome: Treatment with mycophenolate mofetil.","volume":"19","author":"Gellermann","year":"2004","journal-title":"Pediatr Nephrol"},{"key":"R26-21-20230208","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1034\/j.1399-3046.2002.02039.x","article-title":"Universal approach to pharmacokinetic monitoring of immunosuppressive agents in children.","volume":"6","author":"Filler","year":"2002","journal-title":"Pediatr Transplant"},{"key":"R27-21-20230208","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1111\/j.1365-2710.2008.00973.x","article-title":"A limited sampling strategy for estimating mycophenolic acid area under the curve in adult heart transplant patients treated with concomitant cyclosporine.","volume":"34","author":"Pawinski","year":"2009","journal-title":"J Clin Pharm Ther"},{"key":"R28-21-20230208","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1681\/ASN.2008030287","article-title":"New equations to estimate GFR in children with CKD.","volume":"20","author":"Schwartz","year":"2009","journal-title":"J Am Soc Nephrol"},{"key":"R29-21-20230208","doi-asserted-by":"crossref","first-page":"2024","DOI":"10.1093\/ndt\/gfg349","article-title":"A comparison between cystatin C, plasma creatinine and the Cockcroft and Gault formula for the estimation of glomerular filtration rate.","volume":"18","author":"Hoek","year":"2003","journal-title":"Nephrol Dial Transplant"}],"container-title":["Journal of the American Society of Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00001751-201310000-00021","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T19:23:03Z","timestamp":1786130583000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00001751-201310000-00021"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,10]]},"references-count":24,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2013]]}},"URL":"https:\/\/doi.org\/10.1681\/asn.2012121200","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.718052099.793483533","asserted-by":"object"}]},"ISSN":["1046-6673"],"issn-type":[{"value":"1046-6673","type":"print"}],"subject":[],"published":{"date-parts":[[2013,10]]}}}